Effect of fiber-protein supplement on obesity indicators

Evaluation the effect of Yasinazh fiber-protein supplement on anthropometric indices and cardio-metabolic markers in obese or overweight workers; a randomized double-blinded clinical trial

Status

Recruiting

Phases

Phase 3

Study type

Interventional

Source

IRCT

Registry ID

IRCT20240919063095N1

Enrollment

Registered

2024-11-11

Start date

2024-11-21

Completion date

Unknown

Last updated

2025-01-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Obesity and overweight. Obesity, unspecified

Interventions

Intervention 1: Intervention group: daily intake of fiber-protein supplement (25 grams of fiber + 15 grams of whey protein) for 8 weeks. Intervention 2: Control group: receiving placebo for 8 weeks.

Eligibility

Sex/Gender

Male

Age

18 Years to 65 Years

Inclusion criteria

Inclusion criteria: Willingness to participate in the study Employment in Torbat Heydariyeh cement factory as a worker Being overweight according to the standards of the World Health Organization No smoking and alcohol Not using any kind of food supplements during the last two months Not having any history of chronic or acute illness Age 18 to 65 years

Exclusion criteria

Exclusion criteria: Unwillingness to participate in the intervention Having a specific or chronic disease Supplement or medicine use

Design outcomes

Primary

Measure	Time frame
Fasting Blood Sugar. Timepoint: At the beginning and end of the intervention. Method of measurement: Glucose oxidase enzymatic method.;HbA1c. Timepoint: At the beginning and end of the intervention. Method of measurement: Calorimetric method.;CRP. Timepoint: At the beginning and end of the intervention. Method of measurement: using the autoanalyzer method and using the BT3500 device.;ESR. Timepoint: At the beginning and end of the intervention. Method of measurement: using the autoanalyzer method and using the BT3500 device.;Lipid Profle. Timepoint: At the beginning and end of the intervention. Method of measurement: Using biochemical kits.;Blood Pressure. Timepoint: At the beginning and end of the intervention. Method of measurement: Using a mercury sphygmomanometer.	—

Measure

Time frame

Fasting Blood Sugar. Timepoint: At the beginning and end of the intervention. Method of measurement: Glucose oxidase enzymatic method.;HbA1c. Timepoint: At the beginning and end of the intervention. Method of measurement: Calorimetric method.;CRP. Timepoint: At the beginning and end of the intervention. Method of measurement: using the autoanalyzer method and using the BT3500 device.;ESR. Timepoint: At the beginning and end of the intervention. Method of measurement: using the autoanalyzer method and using the BT3500 device.;Lipid Profle. Timepoint: At the beginning and end of the intervention. Method of measurement: Using biochemical kits.;Blood Pressure. Timepoint: At the beginning and end of the intervention. Method of measurement: Using a mercury sphygmomanometer.

—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactDr. Naseh Pahlavani

Torbate-Heidaria University of Medical Sciences

nasehpahlavanine91@yahoo.com+98 937 608 1205

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026